Cephalon’s Paul Harmon joins IPHA board
pharmafile | January 10, 2011 | Appointment | Sales and Marketing | Cephalon, IPHA, Paul Harmon, appointment, sales and marketing
Cephalon’s Paul Harmon has been elected to the prescription medicines division strategy board of Irish pharma association IPHA, a role he will serve in for three years.
Paul joined Cephalon Pharma (Ireland) Limited in 2006 as national sales manager and was appointed as business unit director Ireland and chief representative to IPHA in 2008.
He has over 10 years experience in the pharmaceutical and biopharmaceutical industry in Ireland and internationally, having joined Pfizer Healthcare Ireland in 1999 following a stint in mental health nursing.
Related Content
Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …
Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …
Lonza CEO to step down in 2020
It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to …